# A Study of LY3522348 in Healthy Participants

> **NCT04559568** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 65 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3522348
- **DRUG:** Placebo
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT04559568
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-15
- **Primary completion:** 2021-08-17
- **Final completion:** 2021-08-17
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2025-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04559568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04559568, "A Study of LY3522348 in Healthy Participants". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04559568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*